- Home
- / Day One Biopharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Day One Biopharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$14.4
2024-10-29
Market Capitalization
$1.4 B
2024-10-29
Revenue
$158.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 131.2M | 158.2M | |||
| General and administrative expense | 29.2M | 61.3M | 75.5M | 115.5M | 120.6M |
| Operating expense total | 146.9M | 206.1M | 343.2M | 268.7M | |
| EBIT | (72.7M) | (146.9M) | (206.1M) | (217.3M) | (127.7M) |
| EBIT margin, % | -165.7% | -80.8% | |||
| Investment income | 17.2M | 19.7M | 18.5M | ||
| Interest expense | 4.0K | 4.7M | |||
| Income tax expense | 7.1M | (2.0M) | |||
| Net Income | (72.8M) | (142.2M) | (188.9M) | (95.5M) | (107.3M) |
| EPS | (2.2) | (2.4) | (1.0) | (1.0) |